Bank of Montreal’s Chembio diagnostics, Inc. CEMI Stock Holding History

Bank of Montreal’s Portfolio CEMI Stock Details CEMI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-10,575	Closed	-$47K	–	5549
2021 Q1	$47K	Sell	10,575 -352	-3%	-$1.96K	﹤0.01%	3736
2020 Q4	$58K	Buy	10,927 +2,337	+27%	+$12.1K	﹤0.01%	3874
2020 Q3	$42K	Buy	8,590 +6,989	+437%	+$33.1K	﹤0.01%	3517
2020 Q2	$7K	Buy	+1,601	New	+$15.2K	﹤0.01%	4360

Other funds holding CEMI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

TEE

Tibra Equities Europe London, United Kingdom $90.4M AUM 37.81% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Bank of Montreal's CEMI Position: Q2 2021 in Review

Bank of Montreal sold out of Chembio diagnostics, Inc. (CEMI) in Q2 2021, closing a stake of 10,575 shares — an estimated $47K sold.

Bank of Montreal first reported a position in CEMI in Q2 2020 and held it in 4 quarters. The position peaked at $58K in Q4 2020. 60 funds tracked by Wall St. Rank hold CEMI as of Q2 2021.

Bank of Montreal reported no remaining Chembio diagnostics, Inc. position as of Q2 2021 after selling out during the quarter.
Bank of Montreal sold 10,575 Chembio diagnostics, Inc. shares in Q2 2021, an estimated $47K.
Bank of Montreal first reported a position in Chembio diagnostics, Inc. in Q2 2020 and held it in 4 quarters.
Bank of Montreal's Chembio diagnostics, Inc. position peaked at $58K in Q4 2020.
60 funds tracked by Wall St. Rank held Chembio diagnostics, Inc. as of Q2 2021.

Based on Bank of Montreal's 13F filing for Q2 2021, filed 12 Aug 2021.